Literature DB >> 18836487

APC and the three-hit hypothesis.

S Segditsas1, A J Rowan, K Howarth, A Jones, S Leedham, N A Wright, P Gorman, W Chambers, E Domingo, R R Roylance, E J Sawyer, O M Sieber, I P M Tomlinson.   

Abstract

The seminal 'two-hit hypothesis' implicitly assumes that bi-allelic tumour suppressor gene (TSG) mutations cause loss of protein function. All subsequent events in that tumour therefore take place on an essentially null background for that TSG protein. We have shown that the two-hit model requires modification for the APC TSG, because mutant APC proteins probably retain some function and the two hits are co-selected to produce an optimal level of Wnt activation. We wondered whether the optimal Wnt level might change during tumour progression, leading to selection for more than two hits at the APC locus. Comprehensive screening of a panel of colorectal cancer (CRC) cell lines and primary CRCs showed that some had indeed acquired third hits at APC. These third hits were mostly copy number gains or deletions, but could be protein-truncating mutations. Third hits were significantly less common when the second hit at APC had arisen by copy-neutral loss of heterozygosity. Both polyploid and near-diploid CRCs had third hits, and the third hits did not simply arise as a result of acquiring a polyploid karyotype. The third hits affected mRNA and protein levels, with potential functional consequences for Wnt signalling and tumour growth. Although some third hits were probably secondary to genomic instability, others did appear specifically to target APC. Whilst it is generally believed that tumours develop and progress through stepwise accumulation of mutations in different functional pathways, it also seems that repeated targeting of the same pathway and/or gene is selected in some cancers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18836487     DOI: 10.1038/onc.2008.361

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  29 in total

1.  Translating cancer 'omics' to improved outcomes.

Authors:  Emily A Vucic; Kelsie L Thu; Keith Robison; Leszek A Rybaczyk; Raj Chari; Carlos E Alvarez; Wan L Lam
Journal:  Genome Res       Date:  2012-02       Impact factor: 9.043

Review 2.  Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer.

Authors:  Lu Zhang; Jerry W Shay
Journal:  J Natl Cancer Inst       Date:  2017-08-01       Impact factor: 13.506

3.  Identification of novel mutations by exome sequencing in African American colorectal cancer patients.

Authors:  Hassan Ashktorab; Mohammad Daremipouran; Joe Devaney; Sudhir Varma; Hamed Rahi; Edward Lee; Babak Shokrani; Russell Schwartz; Michael L Nickerson; Hassan Brim
Journal:  Cancer       Date:  2014-09-23       Impact factor: 6.860

4.  A novel AXIN2 germline variant associated with attenuated FAP without signs of oligondontia or ectodermal dysplasia.

Authors:  B Rivera; J Perea; E Sánchez; M Villapún; E Sánchez-Tomé; F Mercadillo; M Robledo; J Benítez; M Urioste
Journal:  Eur J Hum Genet       Date:  2013-07-10       Impact factor: 4.246

5.  A simple algebraic cancer equation: calculating how cancers may arise with normal mutation rates.

Authors:  Peter Calabrese; Darryl Shibata
Journal:  BMC Cancer       Date:  2010-01-05       Impact factor: 4.430

6.  One-hit wonders of genomic instability.

Authors:  Alexander V Strunnikov
Journal:  Cell Div       Date:  2010-05-19       Impact factor: 5.130

7.  Down-regulation of serum/glucocorticoid regulated kinase 1 in colorectal tumours is largely independent of promoter hypermethylation.

Authors:  Francesca Lessi; Andrew Beggs; Mariagrazia de Palo; Marcello Anti; Raffaele Macarone Palmieri; Simona Francesconi; Vito Gomes; Generoso Bevilacqua; Ian Tomlinson; Stefania Segditsas
Journal:  PLoS One       Date:  2010-11-05       Impact factor: 3.240

8.  Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications.

Authors:  Erika L Abel; Joe M Angel; Kaoru Kiguchi; John DiGiovanni
Journal:  Nat Protoc       Date:  2009-08-27       Impact factor: 13.491

9.  A mitotic recombination map proximal to the APC locus on chromosome 5q and assessment of influences on colorectal cancer risk.

Authors:  Kimberley Howarth; Susanna Ranta; Eitan Winter; Ana Teixeira; Helmut Schaschl; John J Harvey; Andrew Rowan; Angela Jones; Sarah Spain; Susan Clark; Thomas Guenther; Aengus Stewart; Andrew Silver; Ian Tomlinson
Journal:  BMC Med Genet       Date:  2009-06-10       Impact factor: 2.103

10.  Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor.

Authors:  Mats Jönsson; Anna Ekstrand; Thomas Edekling; Jakob Eberhard; Dorthe Grabau; David Borg; Mef Nilbert
Journal:  BMC Clin Pathol       Date:  2009-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.